期刊文献+

肝移植术后早期环孢素微乳剂的应用体会 被引量:5

The application of Neaoral in the early stage of liver transplantation
原文传递
导出
摘要 通过对两例成功的背驮式原位肝移植术后早期环孢素的应用观察,我们发现:(1)术后早期移植肝对环孢素的耐受能力较差,环孢素引起移植肝中毒主要表现在以直接胆红素升高为主的阻塞性黄疸,而对丙氨酸转氨酶(ALT)恢复无明显影响。(2)与肾移植不同,移植肝往往在早期排斥和中毒并存。术后1周左右容易发生急性排斥,术后2~3周后可能会出现一定程度的免疫耐受。(3)术后口服环孢素最好用环孢素微乳剂(Neoral),浓度适宜控制在300~500ngml-1(多抗法),术后近期有必要加用抗淋巴细胞球蛋白(ALG)10~15天。 Two cases of piggyback liver transplantation was given cyclosporine A (CsA) in the early stage after operation. It was found that: (1) The tolerance of the transplanted liver in the early stage to CsA was poor. The hepatotoxicity induced by CsA mainly revealed the increase of direct bilirubin (DBIL) without obvious influence on the ALT; (2) The rejection reaction and hepatotoxicity coexisted in the early stage of liver transplantation, which was different from that of kidney transplantation. Acute rejection reaction easily occurred about one week after operation and some degree of immunotolerance emerged at 2nd or 3rd week after operation; (3) When CsA given orally after operation, it is better to use Neaoral with the range of concentration of CsA between 300 to 500 ng\5ml-1. Additionally, it is necessary to use antilymphocyte globulin for 1015 days to make the transplanted liver smoothly recover without rejection and hepatoxicity.
出处 《中华器官移植杂志》 CAS CSCD 1998年第2期74-75,共2页 Chinese Journal of Organ Transplantation
关键词 背驮式 肝移植 环孢素 微乳剂 Piggyback\ \ Liver transplantation\ \ Cyclosporine A
  • 相关文献

同被引文献83

  • 1王昕,修赤英,赵环宇,孙云川.环孢素A的治疗浓度及其影响因素[J].首都医药,2004,11(22):43-46. 被引量:6
  • 2董砚虎.环孢霉素A与I型糖尿病[J].国外医学(内分泌学分册),1994,14(4):198-199. 被引量:3
  • 3李秀萍,曹红兵,王毅民.肝移植患者全血环孢素A谷浓度的测定[J].中国药物与临床,2005,5(8):612-613. 被引量:1
  • 4Foo NC, Ahn BY, Ma X, et al .Cellular vacuolization and apoptois induced by hepatitis B virus large surface prolein [J ]. Hepatology, 2002,36(6) : 1 400. 被引量:1
  • 5Ben Ari Z, Pappo O, Mor E.Intrahepatic cholestasis after liver tromsplantation [J] . Liver Transpl, 2003, 9(10):1005. 被引量:1
  • 6Mamiya S, Itoh T,Miura AB.Acquired pure red cell aplasia in Japan[J ] . Eur J Haematol, 1997,59(1) : 199. 被引量:1
  • 7Jonasova A, Neuwirtova R, Cermak J, et al . cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaem ias without hypoplastic bone marrow[J] .Br J Haematol , 1998,100(2) : 304. 被引量:1
  • 8Takanashi M, Kadono Y, Tabata Y, et al.Successful immunosuppressive therapy for a patient with hypoplastic myelody splastic syndrome[J]. Rinsho Ketsueki,1999,40(3):1 093. 被引量:1
  • 9Emilia G,Mcssora C,longo G,et al.long-term salvage treatment by cyclosporine in refractory autoimmune haematological disorders[J].Br J haematol, 1996, 93(2) :341. 被引量:1
  • 10Nademance A, Sehmidt GM, Parker P, et al .The outcome of matched unrelated donor bone marrow transplantafion in patients with hematologic malignancies using molecular typing for donor selection ang graftversushost diease prophylaxis regimen of cyclosporin,methotrexate and prednisone[J ]. Blood, 1995.86(3), 1 228. 被引量:1

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部